Category: Press Release

Announcing our newest location in the Pacific Northwest

We are thrilled to officially announce our newest clinic location near Portland, Oregon in the Pacific Northwest!

Dr. Shannel Adams and Dr. Angeline Beltsos

Vios is led by Chief Medical Officer/CEO Dr. Angie Beltsos, who is board certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility (REI), practicing medicine since 1991. The new location will feature Shannel R. Adams, MD, FACOG, at the helm – a Portland native and double board-certified OB/GYN and reproductive endocrinologist.

“We are thrilled to have Dr. Adams leading our Pacific Northwest office,” explains Dr. Beltsos. “Her extensive knowledge and dedication to helping people build families is completely aligned with our Vios core values of vision, innovation, teamwork, and passion. Together, we look forward to leading the way toward expanded innovative and patient-centric fertility care options in the Pacific Northwest.”

Highly skilled in all areas of reproductive health, Dr. Adams has a particular expertise and interest in, fertility preservation, male fertility, third party reproduction, and holistic care of both mind and body. She received her undergraduate degree focusing on ethics from Duke University and went on to medical school at Oregon Health and Science University where she graduated in June 2010. Dr. Adams has been recognized with many awards for her contributions to the fields of medicine, reproductive endocrinology, and family planning and has presented numerous times on the topics of Oncofertility, fertility preservation, chromosome screening technologies, and infertility.  She credits her close-knit family and strong female role models with inspiring her to choose medicine as a profession and reproductive endocrinology as her specialty. Taking care of women and playing a trusted role in their healthcare is her passion. She considers it an honor to have an intimate role in the lives of her patients as they build their family or empower themselves with preservation options.

“I’m excited to join the Vios team to help expand our unique approach to fertility care services to the Pacific Northwest,” explains Dr. Adams. “I have the best of both worlds -to be in a community I love while also being able to bring new innovations and cutting-edge technology to offer a greater chance of success for my patients.”

Vios provides patients with innovative, cutting-edge fertility treatment options to meet the diverse needs of their family planning goals. As a team, they strive to be open-minded and forward thinking when evaluating new data, research and technologies that have the potential to improve the care and results they provide to patients.

Vios Fertility Institute – Pacific Northwest is located at 2501 NE 134th Street, Suite 100, Vancouver, Washington 98686.  For more information or to make an appointment, please call 866.955.0766 or complete our online form here.

Read the full press release.

We Welcome Center for Reproductive Health and Dr. Scott Springer to Our Team

Vios Fertility Institute Physicians, Dr. Springer, Dr. Jeelani, Dr. Beltsos, and Dr. Louden.

We are proud to officially announce the acquisition of Center for Reproductive Health, a widely-respected fertility practice founded by Dr. Scott Springer with locations in Crest Hill, IL and Geneva, IL. Read our full press release here.

A board-certified physician who specializes in Reproductive Endocrinology and Infertility, Springer became disenchanted early in his career with the standard practice business model that had nurses and technicians doing most of the work.  While still early in his career, Springer desired a better way to serve and care for his patients, so in 2001 he introduced the Center for Reproductive Health with a commitment to providing fertility treatments in a one on one personalized patient setting.

Vios is led by CEO and Chief Medical Officer Dr. Angeline Beltsos, who is board certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility (REI), practicing medicine since 1991.  Dr. Beltsos, along with Vios physicians including Dr. Roohi Jeelani and Dr. Erica Louden, will join Dr. Springer in serving patients at the Crest Hill and Geneva locations.

“We are honored to have Dr. Springer join the team and bring his incredible reputation, passion and expertise for building families to Vios,” explains Dr. Beltsos.  “We are excited to partner with him to increase our services and access to fertility care to the Western and Southwest suburbs of Chicago.”

Vios Fertility Institute now has 11 locations in the Chicagoland, Milwaukee, and St. Louis regions and accepts a wide range of insurance options. To schedule an appointment, click here.

Vios Fertility Institute Patients Are First to Have Embryos Transferred to TMRW

As Egg Freezing and IVF Rates Hit New Highs, Vios Fertility Institute Goes LIVE with TMRW, the World’s First Technology Platform that Stores, Manages, and Identifies Frozen Eggs and Embryos

Chicago Couple is First to Have Embryos Transferred

 

CHICAGO, IL (February 3, 2021) – By the year 2100, approximately 300 million people will be born from in vitro fertilization (IVF), something that seemed impossible until the birth of Louise Brown in 1978. TMRW Life Sciences (“TMRW”) is determined to assist in those future births by effectively managing all frozen fertility specimens with the first and only automated technology platform that safely stores, manages and identifies frozen eggs and embryos. Today, Vios Fertility Institute – Chicago announces it is the first clinic to go live and begin storing patient specimens.

TMRW technology platform at Vios“No one undertaking IVF should ever have to worry about the safety of their embryos and eggs,” said Joshua Abram, Founder and Co-CEO of TMRW. “Three hundred million babies are expected to be born via IVF globally by 2100. With TMRW we have brought the safe storage and management of life’s most precious cells into the 21st Century.”

TMRW is the solution to a wide range of issues that have plagued fertility clinics through the years such as embryo mix-ups, incorrect transfers of embryos and catastrophic failures that resulted in the loss of thousands of irreplaceable eggs and embryos. While current methods are manual and labor intensive, they have remained unchanged since the advent of IVF. TMRW’s technology automates and digitizes the entire process, which helps reduce the risk for human error and more importantly, allows the clinic to individually track eggs and embryos 24/7 through remote monitoring, sensors and state of the art software.

Additionally, TMRW’s automated solution improves IVF by replacing the current archaic system of storage — which is not equipped to handle the soon to be hundreds of millions of fertility specimens — with a cryo-robot featuring secure, reliable technology that dramatically reduces risk and provides peace of mind.

“As we see a substantial increase in patients seeking IVF and in egg freezing – up 41% percent and 31.5% over the previous year – I am thrilled that Vios is the first fertility clinic in the world that offers TMRW to its patients,” explains Dr. Angie Beltsos, CEO & Chief Medical Officer of Vios Fertility Clinic. “IVF patients and those wanting to preserve their fertility deserve the most sophisticated care available, and there is nothing more powerful than combining our top-notch embryology services with TMRW’s game-changing technology. The peace of mind the TMRW platform offers extends to doctors, embryologists and patients alike.”

Chicago couple, Mayrav Dolgin and Renee Genova, have received fertility treatments at Vios Fertility Clinic resulting in two beautiful sons -Jonah age 2 and Elan 6 mos. They are the first patients of Vios to have their remaining embryos stored using TMRW’s new platform.

“The fertility journey can be difficult enough without having to worry about the safety of your embryos,” explains Dolgin. “Mayrav and I were ecstatic to learn that our precious embryos would be the first to be stored in the TMRW cryo-robot,” adds Genova. “Knowing that our remaining embryos will be cared for and looked after with the most advanced technology available gives us tremendous reassurance that our ability to continue building our family in the future is protected.”

The TMRW platform’s key proprietary features include:

  • A 24/7 state-of-the-art, cloud-based monitoring system that makes thousands of wellness checks on stored samples every day. TMRW’s onsite and remote communication system uses predictive analytics to proactively identify and address any safety or storage trends before they become issues.
  • Each patient is assigned an RFID tag with a unique identifier, enabling clinics to identify and track every fertility cell, dramatically reducing the possibility of mislabeled or missing samples.
  • An encrypted, HIPAA-compliant software system, providing the highest level of data privacy and security available.
  • Proprietary labware with thermal properties and proven storage freezer provides the ability to maintain safe cryogenic temperatures to safeguard eggs and embryos even without electrical power or human intervention for more than two weeks, in case of severe emergencies such as natural disasters.

Towards the end of the year, TMRW plans to launch an app that will allow patients to track their frozen specimens using a smartphone. By the end of 2021, TMRW’s platform will be used in leading fertility clinics comprising more than 30% of all IVF cycles in the U.S. The company hopes to expand into UK-based fertility clinics in summer of 2021.

About Vios Fertility:
Established in 2015, Vios Fertility Institute is one of the fastest growing fertility clinics in the U.S. with 11 locations in the Chicago, Milwaukee and St. Louis regions. Woman owned, the Vios mission is to help patients find their way to fertility health with the highest chances of success. Vios offers innovative, scientific, and cutting-edge treatment options along with an unparalleled patient experience. www.ViosFertility.com

About TMRW Life Sciences:
TMRW has created the world’s first automated platform designed specifically for cryo-management of eggs and embryos used in IVF. TMRW’s RFID-enabled, complete digital chain of custody SaaS technology radically improves on the error-prone manual and analog methods that have gone unchanged throughout the history of IVF, significantly reducing the chances of implantation mix-ups or loss of eggs and embryos. The TMRW team includes many of the world’s most celebrated innovators in fertility, embryology, cryo-management, automation, software development and robotics to name a few of the disciplines involved. TMRW’s co-founders, Joshua Abram, Alan Murray, and Dr. Jeffrey Port, are serial tech and life sciences entrepreneurs. Their immediate prior ventures sold for a combined sum of more than $1 billion. To date, TMRW has raised $50 million. For more information, please visit TMRW.org.

 

A Message From Vios

March 15, 2018

Dear Patients and Friends of Vios Fertility Institute,

In recent news, fertility clinics in both Cleveland and San Francisco experienced a situation where storage tanks holding frozen tissue malfunctioned potentially damaging thousands of eggs and embryos. As of today, it appears that over 500 patients may have been affected between the two programs. These extremely rare occurrences are a stark reminder of the importance we place on cryogenic systems that hold frozen eggs, embryos, sperm and other tissue at IVF clinics. Read some cryopreservation FAQs here.

We share in the sadness for all those involved including patients and their team of care providers. These clinics are very well respected in the field of fertility and this reminds us that things can occur from natural disasters, technical malfunction and the element of human error. Moreover, we want to take a moment to reassure you about the safety of your eggs, embryos and/or sperm that is stored with Vios Fertility Institute. It is also important for an organization to remember what they stand for and value. At Vios, our core values are Vision, Innovation, TeamwOrk and PaSsion. (more…)